These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 28714400

  • 21. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W, Sağlık BN, Levent S, Korkut B, Ilgın S, Özkay Y, Kaplancıklı ZA.
    Molecules; 2018 Aug 14; 23(8):. PubMed ID: 30110946
    [Abstract] [Full Text] [Related]

  • 22. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S, Loganathan C, Sakayanathan P, Karthikeyan S, Stephen AD, Marimuthu DK, Ravichandran S, Sivalingam V, Thayumanavan P.
    Int J Biol Macromol; 2021 Aug 31; 185():750-760. PubMed ID: 34216669
    [Abstract] [Full Text] [Related]

  • 23. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
    Zeb A, Hameed A, Khan L, Khan I, Dalvandi K, Choudhary MI, Basha FZ.
    Med Chem; 2014 Aug 31; 10(7):724-9. PubMed ID: 24875826
    [Abstract] [Full Text] [Related]

  • 24. Synthesis of novel 1,2,3 triazole derivatives and assessment of their potential cholinesterases, glutathione S-transferase enzymes inhibitory properties: An in vitro and in silico study.
    Çelik F, Türkan F, Aras A, Atalar MN, Karaman HS, Ünver Y, Kahriman N.
    Bioorg Chem; 2021 Feb 31; 107():104606. PubMed ID: 33476865
    [Abstract] [Full Text] [Related]

  • 25. Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors.
    Mughal EU, Javid A, Sadiq A, Murtaza S, Zafar MN, Khan BA, Sumrra SH, Tahir MN, Kanwal, Khan KM.
    Bioorg Med Chem; 2018 Jul 23; 26(12):3696-3706. PubMed ID: 29886083
    [Abstract] [Full Text] [Related]

  • 26. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN, Richardson RJ.
    Bioorg Med Chem; 2017 Nov 01; 25(21):5981-5994. PubMed ID: 28986116
    [Abstract] [Full Text] [Related]

  • 27. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
    Tasso B, Catto M, Nicolotti O, Novelli F, Tonelli M, Giangreco I, Pisani L, Sparatore A, Boido V, Carotti A, Sparatore F.
    Eur J Med Chem; 2011 Jun 01; 46(6):2170-84. PubMed ID: 21459491
    [Abstract] [Full Text] [Related]

  • 28. Anti-Alzheimers activity and molecular mechanism of albumin-derived peptides against AChE and BChE.
    Yu Z, Wu S, Zhao W, Ding L, Fan Y, Shiuan D, Liu J, Chen F.
    Food Funct; 2018 Feb 21; 9(2):1173-1178. PubMed ID: 29363710
    [Abstract] [Full Text] [Related]

  • 29. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
    Kumar A, Pintus F, Di Petrillo A, Medda R, Caria P, Matos MJ, Viña D, Pieroni E, Delogu F, Era B, Delogu GL, Fais A.
    Sci Rep; 2018 Mar 13; 8(1):4424. PubMed ID: 29535344
    [Abstract] [Full Text] [Related]

  • 30. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
    Khan I, Ibrar A, Zaib S, Ahmad S, Furtmann N, Hameed S, Simpson J, Bajorath J, Iqbal J.
    Bioorg Med Chem; 2014 Nov 01; 22(21):6163-73. PubMed ID: 25257911
    [Abstract] [Full Text] [Related]

  • 31. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G, Palacios-Esquivel R, Moss DE.
    J Pharmacol Exp Ther; 1995 Aug 01; 274(2):767-70. PubMed ID: 7636741
    [Abstract] [Full Text] [Related]

  • 32. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
    Saxena A, Fedorko JM, Vinayaka CR, Medhekar R, Radić Z, Taylor P, Lockridge O, Doctor BP.
    Eur J Biochem; 2003 Nov 01; 270(22):4447-58. PubMed ID: 14622273
    [Abstract] [Full Text] [Related]

  • 33. 2-Arylbenzofurans from Artocarpus lakoocha and methyl ether analogs with potent cholinesterase inhibitory activity.
    Namdaung U, Athipornchai A, Khammee T, Kuno M, Suksamrarn S.
    Eur J Med Chem; 2018 Jan 01; 143():1301-1311. PubMed ID: 29126732
    [Abstract] [Full Text] [Related]

  • 34. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
    Saud A, Krishnaraju V, Taha A, Kalpana K, Malarkodi V, Durgaramani S, Vinoth Prabhu V, Saleh FA, Ezhilarasan S.
    Eur Rev Med Pharmacol Sci; 2024 Mar 01; 28(6):2522-2537. PubMed ID: 38567612
    [Abstract] [Full Text] [Related]

  • 35. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N, Sıcak Y, Taşkın-Tok T, Öztürk M, Karaküçük-İyidoğan A, Dikmen M, Koçyiğit-Kaymakçıoğlu B, Oruç-Emre EE.
    Eur J Med Chem; 2016 Nov 29; 124():270-283. PubMed ID: 27592396
    [Abstract] [Full Text] [Related]

  • 36. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
    Makhaeva GF, Boltneva NP, Lushchekina SV, Rudakova EV, Serebryakova OG, Kulikova LN, Beloglazkin AA, Borisov RS, Richardson RJ.
    Bioorg Med Chem; 2018 Sep 01; 26(16):4716-4725. PubMed ID: 30104121
    [Abstract] [Full Text] [Related]

  • 37. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S, Jończyk J, Bajda M, Khan IU, Khan MA, Ullah N, Ashraf M, Qurat-ul-Ain, Riaz S, Hussain S, Yar M.
    Bioorg Chem; 2016 Feb 01; 64():13-20. PubMed ID: 26595185
    [Abstract] [Full Text] [Related]

  • 38. Design, synthesis and cholinesterase inhibitory activity of novel spiropyrrolidine tethered imidazole heterocyclic hybrids.
    Almansour AI, Arumugam N, Kumar RS, Kotresha D, Manohar TS, Venketesh S.
    Bioorg Med Chem Lett; 2020 Jan 15; 30(2):126789. PubMed ID: 31753696
    [Abstract] [Full Text] [Related]

  • 39. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.
    Bioorg Med Chem; 2012 Nov 15; 20(22):6669-79. PubMed ID: 23062825
    [Abstract] [Full Text] [Related]

  • 40. Identification of Potent and Selective Acetylcholinesterase/Butyrylcholinesterase Inhibitors by Virtual Screening.
    Xu T, Li S, Li AJ, Zhao J, Sakamuru S, Huang W, Xia M, Huang R.
    J Chem Inf Model; 2023 Apr 24; 63(8):2321-2330. PubMed ID: 37011147
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.